ICUI

SEC source: 0001073397-24-000001 · edgardoc.xml · nonDerivative · entry 3

LOPEZ GEORGE A · CIK 0001073397 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 319,643

F1 · price: All shares sold were sold at the exact price disclosed.

SEC source: 0001698998-24-000001 · edgardoc.xml · derivative · entry 9

Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,792 shares

Expires 2024-03-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: These Securities are Performance-based Restricted Stock Units (PRSU).

F6 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs.

F7 · derivative.exercise_date: These PRSUs were granted on March 7, 2022 and had a 2-year cliff-vest performance period subject to the satisfaction of performance-based metrics and continuous services through the vest date. The PRSUs were approved for vesting in February 2024 by the Compensation Committee at 200% of the original grant.

SEC source: 0001698998-24-000001 · edgardoc.xml · derivative · entry 7

Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 966

Underlying: Common Stock · 966 shares

Expires 2025-03-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F3 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F4 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.

F5 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date.

SEC source: 0001698998-24-000001 · edgardoc.xml · nonDerivative · entry 4

Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,645

SEC source: 0001698998-24-000001 · edgardoc.xml · nonDerivative · entry 3

Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,209

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: These Securities are Performance-based Restricted Stock Units (PRSU).

SEC source: 0001698998-24-000001 · edgardoc.xml · nonDerivative · entry 2

Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,417

SEC source: 0001698998-24-000001 · edgardoc.xml · nonDerivative · entry 1

Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,843

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

SEC source: 0002013412-24-000003 · edgardoc.xml · derivative · entry 10

Sousa Ben · CIK 0002013412 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,574 shares

Expires 2024-03-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: These Securities are Performance-based Restricted Stock Units (PRSU).

F6 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs.

F7 · derivative.exercise_date: These PRSUs were granted on March 7, 2022 and had a 2-year cliff-vest performance period subject to the satisfaction of performance-based metrics and continuous services through the vest date. The PRSUs were approved for vesting in February 2024 by the Compensation Committee at 200% of the original grant.

SEC source: 0002013412-24-000003 · edgardoc.xml · derivative · entry 8

Sousa Ben · CIK 0002013412 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 430

Underlying: Common Stock · 429 shares

Expires 2025-03-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F3 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F4 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.

F5 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date.

SEC source: 0002013412-24-000003 · edgardoc.xml · nonDerivative · entry 4

Sousa Ben · CIK 0002013412 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,049

SEC source: 0002013412-24-000003 · edgardoc.xml · nonDerivative · entry 3

Sousa Ben · CIK 0002013412 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,967

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: These Securities are Performance-based Restricted Stock Units (PRSU).

SEC source: 0002013412-24-000003 · edgardoc.xml · nonDerivative · entry 2

Sousa Ben · CIK 0002013412 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 393

SEC source: 0002013412-24-000003 · edgardoc.xml · nonDerivative · entry 1

Sousa Ben · CIK 0002013412 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 552

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

SEC source: 0001727477-24-000002 · edgardoc.xml · derivative · entry 11

Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,872 shares

Expires 2024-03-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: These Securities are Performance-based Restricted Stock Units (PRSU).

F6 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs.

F7 · derivative.exercise_date: These PRSUs were granted on March 7, 2022 and had a 2-year cliff-vest performance period subject to the satisfaction of performance-based metrics and continuous services through the vest date. The PRSUs were approved for vesting in February 2024 by the Compensation Committee at 200% of the original grant.

SEC source: 0001727477-24-000002 · edgardoc.xml · derivative · entry 10

Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,146

Underlying: Common Stock · 2,145 shares

Expires 2025-03-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F3 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F4 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.

F5 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date.

SEC source: 0001727477-24-000002 · edgardoc.xml · nonDerivative · entry 4

Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,783

SEC source: 0001727477-24-000002 · edgardoc.xml · nonDerivative · entry 3

Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,842

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: These Securities are Performance-based Restricted Stock Units (PRSU).

SEC source: 0001727477-24-000002 · edgardoc.xml · nonDerivative · entry 2

Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 970

SEC source: 0001727477-24-000002 · edgardoc.xml · nonDerivative · entry 1

Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,145

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

SEC source: 0001804831-24-000001 · edgardoc.xml · derivative · entry 11

Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,872 shares

Expires 2024-03-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: These Securities are Performance-based Restricted Stock Units (PRSU).

F6 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs.

F7 · derivative.exercise_date: These PRSUs were granted on March 7, 2022 and had a 2-year cliff-vest performance period subject to the satisfaction of performance-based metrics and continuous services through the vest date. The PRSUs were approved for vesting in February 2024 by the Compensation Committee at 200% of the original grant.

SEC source: 0001804831-24-000001 · edgardoc.xml · derivative · entry 10

Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,146

Underlying: Common Stock · 2,145 shares

Expires 2025-03-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F3 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F4 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.

F5 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date.

SEC source: 0001804831-24-000001 · edgardoc.xml · nonDerivative · entry 4

Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,198

SEC source: 0001804831-24-000001 · edgardoc.xml · nonDerivative · entry 3

Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,257

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: These Securities are Performance-based Restricted Stock Units (PRSU).

SEC source: 0001804831-24-000001 · edgardoc.xml · nonDerivative · entry 2

Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,385

SEC source: 0001804831-24-000001 · edgardoc.xml · nonDerivative · entry 1

Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,560

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

SEC source: 0001410442-24-000002 · edgardoc.xml · derivative · entry 12

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 19,306 shares

Expires 2024-03-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: These Securities are Performance-based Restricted Stock Units (PRSU).

F6 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs.

F7 · derivative.exercise_date: These PRSUs were granted on March 7, 2022 and had a 2-year cliff-vest performance period subject to the satisfaction of performance-based metrics and continuous services through the vest date. The PRSUs were approved for vesting in February 2024 by the Compensation Committee at 200% of the original grant.

SEC source: 0001410442-24-000002 · edgardoc.xml · derivative · entry 11

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,218

Underlying: Common Stock · 3,218 shares

Expires 2025-03-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F3 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F4 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.

F5 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date.

SEC source: 0001410442-24-000002 · edgardoc.xml · nonDerivative · entry 4

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,490

SEC source: 0001410442-24-000002 · edgardoc.xml · nonDerivative · entry 3

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 108,078

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: These Securities are Performance-based Restricted Stock Units (PRSU).

SEC source: 0001410442-24-000002 · edgardoc.xml · nonDerivative · entry 2

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,772

SEC source: 0001410442-24-000002 · edgardoc.xml · nonDerivative · entry 1

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,536

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

SEC source: 0001669639-24-000001 · edgardoc.xml · derivative · entry 10

Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,436 shares

Expires 2024-03-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: These Securities are Performance-based Restricted Stock Units (PRSU).

F7 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs.

F8 · derivative.exercise_date: These PRSUs were granted on March 7, 2022 and had a 2-year cliff-vest performance period subject to the satisfaction of performance-based metrics and continuous services through the vest date. The PRSUs were approved for vesting in February 2024 by the Compensation Committee at 200% of the original grant.

SEC source: 0001669639-24-000001 · edgardoc.xml · derivative · entry 8

Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,073

Underlying: Common Stock · 1,073 shares

Expires 2025-03-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F4 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F5 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.

F6 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date.

SEC source: 0001669639-24-000001 · edgardoc.xml · nonDerivative · entry 4

Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,071

SEC source: 0001669639-24-000001 · edgardoc.xml · nonDerivative · entry 3

Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,600

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: These Securities are Performance-based Restricted Stock Units (PRSU).

SEC source: 0001669639-24-000001 · edgardoc.xml · nonDerivative · entry 2

Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,164

SEC source: 0001669639-24-000001 · edgardoc.xml · nonDerivative · entry 1

Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,751

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

SEC source: 0001073397-24-000001 · edgardoc.xml · nonDerivative · entry 2

LOPEZ GEORGE A · CIK 0001073397 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 335,015

F1 · price: All shares sold were sold at the exact price disclosed.

SEC source: 0001727477-24-000001 · edgardoc.xml · nonDerivative · entry 3

Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.27 to $108.57, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001727477-24-000001 · edgardoc.xml · nonDerivative · entry 2

Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 219

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.22 to $108.18, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001727477-24-000001 · edgardoc.xml · nonDerivative · entry 1

Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,716

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.185 to $107.15 inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-24-000001 · edgardoc.xml · nonDerivative · entry 1

LOPEZ GEORGE A · CIK 0001073397 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 353,969

F1 · price: All shares sold were sold at the exact price disclosed.

SEC source: 0001213900-24-019014 · ownership.xml · nonDerivative · entry 1

SMITHS GROUP PLC · CIK 0001326143 · Former 10% Owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Smiths Group International Holdings Limited

Disclosed balance after: 1,670,000

F1 · balance_after: These shares are held directly by Smiths Group International Holdings Limited ("SGIH"). SGIH is a wholly owned subsidiary of Smiths Group plc ("SGP"). SGP is an indirect beneficial owner of the shares.

SEC source: 0001213900-24-019015 · ownership.xml · nonDerivative · entry 1

Smiths Group International Holdings Ltd · CIK 0001901425 · Former 10% Owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,670,000

F1 · balance_after: These shares are held directly by Smiths Group International Holdings Limited ("SGIH"). SGIH is a wholly owned subsidiary of Smiths Group plc ("SGP"). SGP is an indirect beneficial owner of the shares.

SEC source: 0001410442-24-000001 · edgardoc.xml · derivative · entry 6

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · by Trust

Disclosed balance after: 0

Underlying: Common Stock · 66,000 shares

Expires 2024-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.expiration_date: These non-qualified stock options were granted on 2/24/2014 with a ten year life with an expiration date of 2/24/2024.

SEC source: 0001410442-24-000001 · edgardoc.xml · derivative · entry 5

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 146,366 shares

Expires 2024-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.expiration_date: These non-qualified stock options were granted on 2/24/2014 with a ten year life with an expiration date of 2/24/2024.

SEC source: 0001410442-24-000001 · edgardoc.xml · nonDerivative · entry 4

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · by Trust

Disclosed balance after: 88,698

F1 · kind: Mr. Jain (the Registrant) was personally responsible for cash tax obligations of approximately $5 million in total related to all net exercises reported on this Form 4, shares were not traded in lieu of taxes paid.

F3 · shares: Represents a "net exercise" of outstanding stock options. The trusts received 28,698 shares of common stock on net exercise of option to purchase 66,000 shares of common stock. The company withheld 37,302 shares of common stock underlying the option for payment of the exercise price, using the closing stock price on February 12, 2024 of $104.02.

SEC source: 0001410442-24-000001 · edgardoc.xml · nonDerivative · entry 3

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · by Trust

Disclosed balance after: 126,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001410442-24-000001 · edgardoc.xml · nonDerivative · entry 2

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,318

F1 · kind: Mr. Jain (the Registrant) was personally responsible for cash tax obligations of approximately $5 million in total related to all net exercises reported on this Form 4, shares were not traded in lieu of taxes paid.

F2 · shares: Represents a "net exercise" of outstanding stock options. The reporting person received 63,641 shares of common stock on net exercise of option to purchase 146,366 shares of common stock. The company withheld 82,725 shares of common stock underlying the option for payment of the exercise price, using the closing stock price on February 12, 2024 of $104.02.

SEC source: 0001410442-24-000001 · edgardoc.xml · nonDerivative · entry 1

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 170,043

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.